| Patent application number | Description | Published |
|---|
| 20090129132 | CONTROL DEVICE FOR POWER CONVERTER - A control circuit for a power converter includes a voltage command unit that generates a voltage command signal, a voltage command compensation unit that compensates the voltage command signal to generate a compensatory voltage command signal, and a switching pattern arithmetic unit that generates a switching signal for each of semiconductor switching elements of the power converter based on the compensatory voltage command signal and a carrier wave. The conversional fundamental frequency of the power converter is f and the carrier frequency of the carrier wave is fc. The voltage command compensation unit generates a compensation signal including at least one compensatory frequency component of fc−n×f (where n denotes successive positive and negative integers), and generates the compensatory voltage command signal. | 05-21-2009 |
| 20100271853 | CONTROLLER OF POWER CONVERTER - A controller of a power converter including an inverter that includes plural semiconductor switching elements. The controller suppresses an error between a voltage command and an inverter output voltage and responds to a voltage command at a high speed. The controller includes a voltage command generator that generates a voltage command signal and a switching pattern calculator that calculates and outputs, based on the voltage command signal, a switching pattern of a synchronous PWM system in which an average value of an inverter output voltage matches the voltage command signal. | 10-28-2010 |
| 20100277149 | CONTROLLER OF POWER CONVERTER - A controller that controls a switching element of an inverter using pulse width modulation is applied to a power converter including an inverter, to realize a stable change of a carrier frequency, current control responsiveness, and inverter loss suppression. The controller includes a carrier-frequency setting unit that sets a carrier frequency command used for pulse width modulation of an inverter corresponding to a current command and a current-command change rate. The carrier-frequency setting unit includes a carrier frequency map having mapped thereon information of a carrier frequency corresponding to a current command expressed in a vertical axis and a current-command change rate expressed in a lateral axis, and outputs information of a carrier frequency on the carrier frequency map corresponding to the input current command and the input current-command change rate to a switching pattern calculator. | 11-04-2010 |
| 20100289439 | DRIVING CONTROLLER FOR AC MOTOR - An object is to provide a driving controller for an AC motor that can prevent generation of an excessive voltage between lines of a motor and between contacts of a motor cut-off contactor and a continuous arc between contacts of the motor cut-off contactor, regardless of the type of a fault occurred, even when a phase in which a current zero point is not generated and a phase in which a current zero point is generated coexist in a fault current that flows between an inverter and the motor. A control unit is configured to open a motor cut-off contactor not at a time when a state of a detected current is determined to be abnormal but at a time when the state of the current is determined to be normal, even when a basic contactor-close command MKC0 becomes off (L level). | 11-18-2010 |
| Patent application number | Description | Published |
|---|
| 20090099193 | EML4-ALK FUSION GENE - The present inventors found that a fusion gene present in some cancer patients is an oncogene. The present invention relates to a polypeptide as a novel fusion protein, a polynucleotide encoding the polypeptide, a vector comprising the polynucleotide, a transformed cell comprising the vector, and a therapeutic agent for cancer. | 04-16-2009 |
| 20100099658 | DI(ARYLAMINO)ARYL COMPOUND - The present invention provides a compound which is useful as an inhibitor against the kinase activity of EML4-ALK fusion proteins and mutant EGFR proteins. | 04-22-2010 |
| 20100190826 | BENZIMIDAZOLE DERIVATIVE - Provided is a novel and excellent method for treating and/or preventing benign prostatic hyperplasia, prostate cancer, and the like based on selective inhibitory activity against 17βHSD type 5. It was found that an indole or benzimidazole derivative, where a nitrogen atom of the indole ring or benzimidazole ring is substituted with a phenyl group substituted with COOH, has a potent selective inhibitory activity against 17βHSD type 5 and may become an agent for treating and/or an agent for preventing a disease associated with 17βHSD type 5, such as benign prostatic hyperplasia, prostate cancer and the like, without accompanying adverse effects due to a decrease in testosterone; and the present invention has thus been completed. | 07-29-2010 |
| 20100240673 | EML4-ALK Fusion Gene - The present inventors found that a fusion gene present in some cancer patients is an oncogene. The present invention relates to a polypeptide as a novel fusion protein, a polynucleotide encoding the polypeptide, a vector comprising the polynucleotide, a transformed cell comprising the vector, a method for detecting the fusion protein or polynucleotide, a method for screening a therapeutic agent for cancer, and a method for treating cancer that is shown to be positive for the fusion gene. Further, the present invention relates kit, primer set, and probe useful in the detection of cancer that is shown to be positive for the fusion gene. | 09-23-2010 |
| 20110071146 | 17BetaHSD Type 5 Inhibitor - To provide a novel and excellent method for treating and/or preventing prostatic cancer, benign prostatic hyperplasia, acne, seborrhea, hirsutism, baldness, alopecia, precocious puberty, adrenal hypertrophy, polycystic ovary syndrome, breast cancer, lung cancer, endometriosis, leiomyoma and the like based on selective inhibitory activity against 17βHSD type 5. | 03-24-2011 |
| 20110230545 | EML4-ALK FUSION GENE - The present inventors found that a fusion gene present in some cancer patients is an oncogene. The present invention relates to a polypeptide as a novel fusion protein, a polynucleotide encoding the polypeptide, a vector comprising the polynucleotide, a transformed cell comprising the vector, a method for detecting the fusion protein or polynucleotide, a method for screening a therapeutic agent for cancer, and a method for treating cancer that is shown to be positive for the fusion gene. Further, the present invention relates kit, primer set, and probe useful in the detection of cancer that is shown to be positive for the fusion gene. | 09-22-2011 |
| 20110282066 | SCREENING METHOD FOR SUBSTANCE USEFUL AS AGENT FOR TREATING PROSTATE CANCER - [Object] A screening method for a compound which is useful as an agent for treating 17βHSD type 5-related diseases and/or an agent for treating 17βHSD type 5-related cancer such as prostate cancer is provided. | 11-17-2011 |
